Suchergebnisse - "Feigin, Andrew"

PubPharm (24)

1

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD) : a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

enthalten in: The Lancet. Neurology | 2024

von Reilmann, R. | Anderson, K. | Feigin, A. | +61

2

The Safety of Deutetrabenazine for Chorea in Huntington Disease : An Open-Label Extension Study

enthalten in: CNS drugs | 2022

von Frank, S. | Testa, C. | Edmondson, M. | +105

3

Pepinemab antibody blockade of SEMA4D in early Huntington's disease : a randomized, placebo-controlled, phase 2 trial

enthalten in: Nature medicine | 2022

von Feigin, A. | Evans, E. | Fisher, T. | +49

ErratumIn: Nat Med. 2022 Oct 4;:. - PMID 36195687

4

Trial of Cinpanemab in Early Parkinson's Disease

enthalten in: The New England journal of medicine | 2022

von Lang, A. | Siderowf, A. | Macklin, E. | +99

5

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD) : a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

enthalten in: The Lancet. Neurology | 2019

von Reilmann, R. | McGarry, A. | Grachev, I. | +114

CommentIn: Lancet Neurol. 2019 Feb;18(2):131-133. - PMID 30563777

6

Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity

enthalten in: Science translational medicine | 2018

von Niethammer, M. | Tang, C. | Vo, A. | +9

CommentIn: Nat Rev Neurol. 2019 Jan;15(1):2. - PMID 30542071

7

National randomized controlled trial of virtual house calls for Parkinson disease

enthalten in: Neurology | 2017

von Beck, C. | Beran, D. | Biglan, K. | +50

CommentIn: Neurology. 2017 Sep 12;89(11):1103-1104. - PMID 28814459

8

Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease

enthalten in: JCI insight | 2017

von Niethammer, M. | Tang, C. | LeWitt, P. | +19

9

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

enthalten in: Neurology | 2017

von McGarry, A. | McDermott, M. | Kieburtz, K. | +158

CommentIn: Neurology. 2017 Jan 10;88(2):116-117. - PMID 27913697

10

A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia

enthalten in: Movement disorders : official journal of the Movement Disorder Society | 2016

von Trenkwalder, C. | Berg, D. | Rascol, O. | +30